Publications by authors named "P V Dudina"

GPR55 is a non-canonical cannabinoid receptor, important for cancer proliferation. Depending on the ligand, it induces either cell proliferation or death. The objective of the study was to establish the mechanisms of this multidirectional signaling.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on creating co-delivery systems using paclitaxel and a prodrug of etoposide, utilizing human serum albumin (HSA) and poly(lactide-co-glycolide) nanoparticles.
  • The nanoparticles were analyzed for various properties and demonstrated sizes of 90-150 nm, showing effective cytotoxicity against glioma cells, particularly Neuro2A cells.
  • The results indicated a synergistic effect of the drug combinations, suggesting these delivery systems could enhance chemotherapy treatments for brain tumors, marking a novel approach using HSA-based formulations.
View Article and Find Full Text PDF

Natural cytokinines are a promising group of cytoprotective and anti-tumor agents. In this research, we synthesized a set of aryl carbamate, pyridyl urea, and aryl urea cytokinine analogs with alkyl and chlorine substitutions and tested their antiproliferative activity in MDA-MB-231, A-375, and U-87 MG cell lines, and cytoprotective properties in HO and CoCl models. Aryl carbamates with the oxamate moiety were selectively anti-proliferative for the cancer cell lines tested, while the aryl ureas were inactive.

View Article and Find Full Text PDF

Stabilized melanocortin analog peptide ACTH(6-9)PGP (HFRWPGP) possesses a wide range of neuroprotective activities. However, its mechanism of action remains poorly understood. In this paper, we present a study of the proproliferative and cytoprotective activity of the adrenocorticotropic hormone fragment 6-9 (HFRW) linked with the peptide prolyine-glycyl-proline on the SH-SY5Y cells in the model of oxidative stress-related toxicity.

View Article and Find Full Text PDF

GPR55 is a GPCR of the non-CB1/CB2 cannabinoid receptor family, which is activated by lysophosphatidylinositol (LPI) and stimulates the proliferation of cancer cells. Anandamide, a bioactive lipid endocannabinoid, acts as a biased agonist of GPR55 and induces cancer cell death, but is unstable and psychoactive. We hypothesized that other endocannabinoids and structurally similar compounds, which are more hydrolytically stable, could also induce cancer cell death via GPR55 activation.

View Article and Find Full Text PDF